Tcg Crossover Management, LLC Savara Inc Transaction History
Tcg Crossover Management, LLC
- $612 Million
- Q4 2024
A detailed history of Tcg Crossover Management, LLC transactions in Savara Inc stock. As of the latest transaction made, Tcg Crossover Management, LLC holds 12,362,205 shares of SVRA stock, worth $32.1 Million. This represents 6.2% of its overall portfolio holdings.
Number of Shares
12,362,205
Previous 12,362,205
-0.0%
Holding current value
$32.1 Million
Previous $52.4 Million
27.6%
% of portfolio
6.2%
Previous 6.8%
Shares
2 transactions
Others Institutions Holding SVRA
# of Institutions
141Shares Held
158MCall Options Held
55.6KPut Options Held
600-
Nea Management Company, LLC Timonium, MD24.5MShares$63.6 Million5.37% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA14.6MShares$37.9 Million12.07% of portfolio
-
Vestal Point Capital, LP New York, NY10.8MShares$28 Million1.96% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.66MShares$22.5 Million1.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.31MShares$21.6 Million0.0% of portfolio
About Savara Inc
- Ticker SVRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 114,043,000
- Market Cap $297M
- Description
- Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.